Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

349
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
349
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

301
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
301

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignancy in neuromuscular patients on chronic IVIG.

Frontiers in neurology·2025
Same author

Global Dynamic Impression for Differentiating Between Epileptic and Psychogenic Nonepileptic Seizures: A Feasibility Study.

Brain and behavior·2025
Same author

The "Stadium" teaching tool for explaining epilepsy to the patient.

Epileptic disorders : international epilepsy journal with videotape·2023
Same author

Knowledge and emotional attitudes of health care practitioners regarding patients with psychogenic nonepileptic seizures.

Arquivos de neuro-psiquiatria·2022
Same author

Using nirmatrelvir/ritonavir in patients with epilepsy: An update from the Israeli chapter of the International League Against Epilepsy.

Epilepsia·2022
Same author

MRI in predicting conversion to multiple sclerosis within 1 year.

Brain and behavior·2018

Related Experiment Video

Updated: Jul 2, 2025

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.4K

Functional seizures: Are they consistent over time?

Elian Bahous1, Raz Wagner1, Moshe Herskovitz1,2

  • 1Department of Neurology, Rambam Health Care Campus, Haifa, Israel.

Brain and Behavior
|February 20, 2024
PubMed
Summary
This summary is machine-generated.

Functional seizures (FS) remain consistent in patients across multiple video EEG monitoring (VEEG) sessions, even years apart. This suggests FS is a stable phenomenon, supporting further research into its origins.

Keywords:
consistencyfunctional seizuresstereotypy

More Related Videos

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
11:54

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy

Published on: January 29, 2018

25.5K
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.4K

Related Experiment Videos

Last Updated: Jul 2, 2025

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.4K
Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
11:54

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy

Published on: January 29, 2018

25.5K
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.4K

Area of Science:

  • Neurology
  • Neuroscience
  • Clinical Neurophysiology

Background:

  • Previous research indicated functional seizures (FS) are consistent within a single video EEG monitoring (VEEG) session.
  • This study investigated the long-term consistency of FS across separate VEEG sessions over several years.

Purpose of the Study:

  • To determine if functional seizures (FS) maintain consistency in type, affected regions, and duration across multiple video EEG monitoring (VEEG) sessions over extended periods.
  • To assess the correlation between the time interval between VEEG sessions and the degree of FS consistency.

Main Methods:

  • Evaluated FS consistency across VEEG sessions using criteria: seizure type, primary/secondary anatomical regions involved, movement frequency, and duration.
  • Categorized consistency levels as low, moderate, or high based on the number of consistent features across sessions.
  • Analyzed data from 14 patients with a mean interval of 3.8 years between VEEG monitoring.

Main Results:

  • 13 out of 14 patients showed consistency in FS type between their first and second VEEG sessions.
  • Motor FS demonstrated consistency in the main anatomical region (9/12 patients) and other involved regions (9/12 patients).
  • Most patients (10/14) exhibited high consistency in FS, with seizure duration being the least consistent feature.

Conclusions:

  • Functional seizures (FS) demonstrate significant consistency in individual patients over several years, supporting the concept of FS as a stable phenomenon.
  • No clear correlation was found between the time elapsed between VEEG sessions and the degree of FS consistency.
  • Findings suggest potential new research directions for understanding the underlying mechanisms of functional seizures.